Citicoline, Creatine, and Omega-3 Effects in Middle Age Women
This trial is active, not recruiting.
|Treatment||citicoline, omega-3 fatty acids and creatine|
|Start date||February 2012|
|End date||March 2017|
|Trial size||25 participants|
|Trial identifier||NCT01502813, IRB_48136|
The purpose of this study is to determine the functional effects of a citicoline, creatine, and omega-3 fatty acids combination when administered for a duration of four weeks (28 days) to non-psychiatric adult female participants.
|Intervention model||single group assignment|
Change from Baseline in Neuropsychological Tests that measure attention and memory at 14 days
time frame: Baseline and 14 days from baseline
Change from Baseline in Neuropsychological Tests that measure attention and memory at 28 days
time frame: Baseline and 28 days from baseline
Female participants from 40 years up to 60 years old.
Inclusion Criteria: - Female - Age 40-60 years Exclusion Criteria: - Significant medical condition - History of co-morbid psychiatric disorders - Current Axis I or II diagnosis - Past participation in a pharmacotherapeutic trial - Head injury with LOC>5 minutes - Use of psychotropic medication - History of fish allergies - Medical condition associated with clinically significant decreases in coagulability - Use of anticoagulant medication
|Principal investigator||Deborah Yurgelun-Todd, PhD|
|Description||Standard clinical measures for mood and neuropsychological measures of attention, cognitive inhibition and memory will be applied before, during, and after a course of a daily supplementation of citicoline, creatine and omega-3 for 28 days to non-psychiatric adult female participants. We hypothesis that the combination of supplements will improve memory and attention in healthy adult women.|
Call for more information